Under-reporting of antibiotic anaphylaxis may put patients at risk

Lancet

Volumn 353, Issue 9159, 1999, Pages 1157-1158

  Pumphrey, Richard S H ^a   Davis, Sarah ^a  

^a ST MARY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; ANTIBIOTIC AGENT; CEFACLOR; CEPHALOSPORIN; PENICILLIN G;

ANAPHYLAXIS; ARTICLE; BRONCHITIS; CAUSE OF DEATH; CROSS REACTION; DRUG FATALITY; DRUG HYPERSENSITIVITY; DRUG MONITORING; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL;

EID: 0033519010     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)00449-3     Document Type: Article

References (5)

1. Waller P.C., Coulson R.A., Wood S.M. Regulatory pharmacovigilance in the United Kingdom: current principles and practice. Pharmacoepidemiol Drug Saf. 5:1996;363-375.
2. Anne S., Reisman R.E. Risk of administering cephalosporin antibiotics to patients with histories of penicillin allergy. Ann Allergy Asthma Immunol. 74:1995;167-170.
3. Adkinson N.F. Jr. Beta-lactam crossreactivity. Clin Exp Allergy. 28(suppl 4):1998;37-40.
4. British National Formulary. September 1998; 36: 244.
5. Rudolph A.H., Price E.V. Penicillin reactions among patients in venereal disease clinics: a national survey. JAMA. 223:1973;499-501.